5-chloro-4-hydroxyl-2(1H)-pyridone crystal form, preparation method and application thereof
The invention discloses a 5-chloro-4-hydroxyl-2(1H)-pyridone crystal form, a preparation method and application thereof. Intervals of crystal faces d of diffraction peaks in a powder X-ray diffraction diagram of P crystal forms of 5-chloro-4-hydroxyl-2(1H)-pyridone are 5.93, 4.79, 3.46, 3.42, 3.24,...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a 5-chloro-4-hydroxyl-2(1H)-pyridone crystal form, a preparation method and application thereof. Intervals of crystal faces d of diffraction peaks in a powder X-ray diffraction diagram of P crystal forms of 5-chloro-4-hydroxyl-2(1H)-pyridone are 5.93, 4.79, 3.46, 3.42, 3.24, 2.97 and 2.77; and relative peak strengths corresponding to the diffraction peaks are 59, 27, 100, 35, 61, 16 and 22. An alkali-solution and acid-isolation crystallizing method is adopted in the preparation method of the P crystal forms. The crystal forms can be used as a dihydropyrimidine dehydrogenase inhibitor for preparing a drug for treating cancers. The crystal forms have the advantages of better thermodynamic stability, dissolution and bioavailability. The preparation method is simple and easy and suitable for industrialization application. |
---|